Current Status and Prospects of Targeted Therapy for Osteosarcoma

被引:55
作者
Hu, Zunguo [1 ]
Wen, Shuang [1 ]
Huo, Zijun [2 ]
Wang, Qing [3 ]
Zhao, Jiantao [2 ]
Wang, Zihao [1 ]
Chen, Yanchun [2 ]
Zhang, Lingyun [3 ]
Zhou, Fenghua [3 ]
Guo, Zhangyu [3 ]
Liu, Huancai [1 ]
Zhou, Shuanhu [4 ]
机构
[1] Weifang Med Univ, Affiliated Hosp, Sch Clin Med, Dept Joint Surg, Weifang 261061, Peoples R China
[2] Weifang Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Weifang 261053, Peoples R China
[3] Weifang Med Univ, Neurol Disorders & Regenerat Repair Lab, Weifang 261053, Peoples R China
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthped Surg, Boston, MA 02115 USA
关键词
osteosarcoma; targeted therapy; chemotherapy; surgical treatment; HIGH-GRADE OSTEOSARCOMA; GROWTH-FACTOR RECEPTOR; SOFT-TISSUE SARCOMAS; FACTOR-I RECEPTOR; PHASE-II; METASTATIC OSTEOSARCOMA; PHOTODYNAMIC THERAPY; PROGNOSTIC-FACTORS; LIMB SALVAGE; CANCER;
D O I
10.3390/cells11213507
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS prognosis is poor, and improving the survival of OS patients remains a challenge. Current treatment methods such as surgical approaches, chemotherapeutic drugs, and immunotherapeutic drugs remain ineffective. As research progresses, targeted therapy is gradually becoming irreplaceable. In this review, several treatment modalities for osteosarcoma, such as surgery, chemotherapy, and immunotherapy, are briefly described, followed by a discussion of targeted therapy, the important targets, and new technologies for osteosarcoma treatment.
引用
收藏
页数:19
相关论文
共 146 条
  • [1] Photodynamic Therapy of Cancer: An Update
    Agostinis, Patrizia
    Berg, Kristian
    Cengel, Keith A.
    Foster, Thomas H.
    Girotti, Albert W.
    Gollnick, Sandra O.
    Hahn, Stephen M.
    Hamblin, Michael R.
    Juzeniene, Asta
    Kessel, David
    Korbelik, Mladen
    Moan, Johan
    Mroz, Pawel
    Nowis, Dominika
    Piette, Jacques
    Wilson, Brian C.
    Golab, Jakub
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (04) : 250 - 281
  • [2] Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
    Anninga, Jakob K.
    Gelderblom, Hans
    Fiocco, Marta
    Kroep, Judith R.
    Taminiau, Anstoni H. M.
    Hogendoorn, Pancras C. W.
    Egeler, R. Maarten
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (16) : 2431 - 2445
  • [3] Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group
    Arndt, Carola A. S.
    Koshkina, Nadya V.
    Inwards, Carrie Y.
    Hawkins, Douglas S.
    Krailo, Mark D.
    Villaluna, Doojduen
    Anderson, Peter M.
    Goorin, Allen M.
    Blakely, Martin L.
    Bernstein, Mark
    Bell, Sharon A.
    Ray, Kaylee
    Grendahl, Darryl C.
    Marina, Neyssa
    Kleinerman, Eugenie S.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (15) : 4024 - 4030
  • [4] Targeting the VEGF Pathway in Osteosarcoma
    Assi, Tarek
    Watson, Sarah
    Samra, Bachar
    Rassy, Elie
    Le Cesne, Axel
    Italiano, Antoine
    Mir, Olivier
    [J]. CELLS, 2021, 10 (05)
  • [5] Osteosarcoma: prognosis plateau warrants retinoblastoma pathway targeted therapy
    Ballatori, Sarah E.
    Hinds, Philip W.
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2016, 1
  • [6] Target gene-independent functions of MYC oncoproteins
    Baluapuri, Apoorva
    Wolf, Elmar
    Eilers, Martin
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (05) : 255 - 267
  • [7] Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma
    Barani, Mahmood
    Mukhtar, Mahwash
    Rahdar, Abbas
    Sargazi, Saman
    Pandey, Sadanand
    Kang, Misook
    [J]. BIOSENSORS-BASEL, 2021, 11 (02):
  • [8] PDGF family function and prognostic value in tumor biology
    Bartoschek, Michael
    Pietras, Kristian
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (02) : 984 - 990
  • [9] Therapeutic potential of nvp-bkm120 in human osteosarcomas cells
    Bavelloni, Alberto
    Focaccia, Enrico
    Piazzi, Manuela
    Orsini, Arianna
    Ramazzotti, Giulia
    Cocco, Lucio
    Blalock, William
    Faenza, Irene
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 10907 - 10917
  • [10] Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
    Beck, Olaf
    Paret, Claudia
    Russo, Alexandra
    Burhenne, Juergen
    Fresnais, Margaux
    Steimel, Kevin
    Seidmann, Larissa
    Wagner, Daniel-Christoph
    Vewinger, Nadine
    Lehmann, Nadine
    Sprang, Maximilian
    Backes, Nora
    Roth, Lea
    Neu, Marie Astrid
    Wingerter, Arthur
    Henninger, Nicole
    El Malki, Khalifa
    Otto, Henrike
    Alt, Francesca
    Desuki, Alexander
    Kindler, Thomas
    Faber, Joerg
    [J]. CANCERS, 2020, 12 (04)